Prostate Cancer Clinical Trials in Philadelphia, PA

Prostate Cancer Clinical Trials in Philadelphia, PA

View the best 10 prostate cancer medical studies in Philadelphia, Pennsylvania. Access promising new therapies by applying to a Philadelphia-based Prostate Cancer clinical trial.

Top rated prostate cancer clinical trials in Philadelphia, Pennsylvania

Here are the top 10 medical studies for prostate cancer in Philadelphia, Pennsylvania

Image of University of Alabama at Birmingham (UAB) in Birmingham, United States.

Standard of Care Proton Therapy +3 More

Proton Beam Therapy

Recruiting1 award
This trial compares the quality of life, toxicity, and disease control of men with prostate cancer treated with proton therapy vs. IMRT.
Image of Arizona Center for Cancer Care - Gilbert in Gilbert, United States.

ProstAtak® Immunotherapy

Cancer Vaccine

Recruiting1 awardPhase 3
This trial is testing whether adding ProstAtak immunotherapy to radiation therapy can improve outcomes for patients with localized prostate cancer at high or intermediate risk for the disease coming back.
Image of Yale University- Yale Cancer Center in New Haven, United States.

Radium-223 +1 More

Radioactive Agent

Recruiting2 awardsPhase 3
This trial is comparing the efficacy of adding Radium-223 to Docetaxel chemotherapy versus Docetaxel chemotherapy alone in men with metastatic hormone-refractory prostate cancer.
Image of The Urology Center of Colorado in Denver, United States.

Niraparib +2 More

PARP Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing different doses of a new cancer drug, and how well it works with other drugs, in men with prostate cancer that has spread and is resistant to treatment.
Image of University of Florida Health Proton Therapy Institute in Jacksonville, United States.

Proton Beam Therapy +1 More

Radiation

Recruiting1 award
This trial is studying whether men being treated for prostate cancer have the same amount of side effects from either one of two different external radiation treatments: IMRT or PBT.
Image of VA Greater Los Angeles Healthcare System, West Los Angeles, CA in West Los Angeles, United States.

Carboplatin +1 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is comparing the efficacy of two treatments for patients with metastatic castrate resistant prostate cancer who have tumors containing BRCA1, BRCA2 or PALB2 inactivating DNA mutations.
Image of Crozer Keystone Health System/Philadelphia CyberKnife Center in Havertown, United States.

CyberKnife SBRT

Radiation Therapy

Recruiting1 award13 criteria
This trial is testing whether CK-SBRT is an effective treatment for prostate cancer, especially in those with unfavorable types of the disease.
Image of Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers in Chandler, United States.

Talazoparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial looks at whether adding the drug talazoparib to the drug enzalutamide improves progression-free survival in men with metastatic castration-resistant prostate cancer.
Image of Mobile Infirmary Medical Center in Mobile, United States.

Flutamide +3 More

Hormone Therapy

Recruiting1 awardPhase 2 & 3
This trial is testing docetaxel in combination with antiandrogen therapy and radiation therapy versus antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery.
Image of Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities) in Basking Ridge, United States.

Talazoparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 1 & 2
This trial will test the safety of talazoparib plus temozolomide in men with mCRPC.

Popular filter options for prostate-cancer philadelphia trials

Phase 3 Clinical Trials

View 98 phase 3 medical studies.

Clinical Trials With No Placebo

View 98 medical studies that do not have a placebo group.

View More Prostate-cancer Philadelphia Trials

See another 82 medical studies focused on prostate-cancer philadelphia.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.